Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
MCL1 is essential for the survival of stem and progenitor cells of multiple lineages, and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases. B- and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma, however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse. The mechanism of MCL1 overexpression in cancer is not well understood. Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival. USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degradation. Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas. Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis. Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737. These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phosphorylation of MCL1 at S159 and T163 also affects the USP9X-MCL1 interaction [121].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [121]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F. E., Bernd, H.-W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055351 · Cited by 1,006
Maurer, U., Charvet, C., Wagman, A. S., Dejardin, E., & Green, D. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.009 · Cited by 881
Zhong, Q., Gao, W., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.06.009 · Cited by 842
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Cited by
Items 101–200 of 630
Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication
He, M., Zhou, Z., Wu, G. Y., Chen, Q., & Wan, Y. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.03.001 · Cited by 109
DUBs, the regulation of cell identity and disease
Heideker, J., & Wertz, I. E. (2015) · Biochemical Journal · doi:10.1042/bj20140496 · Cited by 98
Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase
Zhao, Y. J., Majid, M. C., Soll, J. M., Brickner, J. R., Dango, S., & Mosammaparast, N. (2015) · The EMBO Journal · doi:10.15252/embj.201490497 · Cited by 115
Synthesis and Evaluation of Derivatives of the Proteasome Deubiquitinase Inhibitor b‐ AP 15
Wang, X., D’Arcy, P., Caulfield, T. R., Paulus, A., Chitta, K. S., Mohanty, C., Gullbo, J., Chanan-Khan, A. A., & Linder, S. T. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12571 · Cited by 106
Grou, C. P. O., Francisco, T., Rodrigues, T. A., Freitas, M. O., Pinto, M. P., Carvalho, A. F., Domingues, P. M., Wood, S. A., Rodríguez-Borges, J. E., Sá-Miranda, C., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340158 · Cited by 110
Gomez‐Bougie, P., Ménoret, E., Juin, P. P., Dousset, C., Pellat‐Deceunynck, C., & Amiot, M. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.118 · Cited by 114
Gores, G. J., & Kaufmann, S. H. (2012) · Genes & Development · doi:10.1101/gad.186189.111 · Cited by 99
Cox, J. L., Wilder, P. J., Gilmore, J. M., Wuebben, E. L., Washburn, M. P., & Rizzino, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062857 · Cited by 105
Edelmann, M. J., Nicholson, B., & Kessler, B. M. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002031 · Cited by 109
Kim, S. M., Yun, M. R., Hong, Y. K., Solca, F., Kim, J.-H., Kim, H.-J., & Cho, B. C. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1188 · Cited by 96
Kirkin, V., & Đikić, I. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.004 · Cited by 101
Acosta-Alvear, D., Cho, M. Y., Wild, T., Buchholz, T. J., Lerner, A. G., Simakova, O., Hahn, J., Korde, N., Landgren, O., Maric, I., et al. (2015) · eLife · doi:10.7554/elife.08153 · Cited by 95
Development of Mcl-1 inhibitors for cancer therapy
Negi, A., & Murphy, P. V. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113038 · Cited by 91
Jie, X., Fong, W. P., Zhou, R., Zhao, Y., Zhao, Y., Meng, R., Zhang, S., Dong, X., Zhang, T., Yang, K., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00740-z · Cited by 106
An Atlas of Altered Expression of Deubiquitinating Enzymes in Human Cancer
Luise, C., Capra, M. C., Donzelli, M., Mazzarol, G., Jodice, M. G., Nuciforo, P. G., Viale, G., Fiore, P. P. D., & Confalonieri, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015891 · Cited by 97
Proteasome-associated deubiquitinases and cancer
Mofers, A., Pellegrini, P., Linder, S., & D’Arcy, P. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9697-6 · Cited by 94
The Essential Role of Evasion from Cell Death in Cancer
Kelly, G. L., & Strasser, A. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-385524-4.00002-7 · Cited by 113
The role of deubiquitinating enzymes in apoptosis
Ramakrishna, S., Suresh, B., & Baek, K. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0504-6 · Cited by 110
Koss, B., Morrison, J., Perciavalle, R. M., Singh, H., Rehg, J. E., Williams, R. T., & Opferman, J. T. (2013) · Blood · doi:10.1182/blood-2012-06-440230 · Cited by 92
Regulation of pluripotency and differentiation by deubiquitinating enzymes
Suresh, B., Lee, J., Kim, S., & Ramakrishna, S. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.53 · Cited by 100
Deubiquitylating Enzymes and DNA Damage Response Pathways
Jacq, X., Kemp, M., Martin, N. M. B., & Jackson, S. P. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9635-3 · Cited by 90
Perturbing mitosis for anti‐cancer therapy: is cell death the only answer?
Haschka, M. D., Karbon, G., Fava, L. L., & Villunger, A. (2018) · EMBO Reports · doi:10.15252/embr.201745440 · Cited by 106
Shen, G., Ye, L., Yang, X., Zhang, J., Xu, Z., & Jia, H. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-393 · Cited by 88
Targeting cyclin-dependent kinases in anti-neoplastic therapy
Bruyère, C., & Meijer, L. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.08.004 · Cited by 95
MGMT-activated DUB3 stabilizes MCL1 and drives chemoresistance in ovarian cancer
Wu, X., Luo, Q., Zhao, P., Chang, W., Wang, Y., Shu, T., Ding, F., Li, B., & Liu, Z. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814742116 · Cited by 89
Drugs targeting Bcl-2 family members as an emerging strategy in cancer
Leber, B., Geng, F., Kale, J., & Andrews, D. W. (2010) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399410001572 · Cited by 88
Toloczko, A. D., Guo, F., Yuen, H., Wen, Q., Wood, S. A., Ong, Y. S., Chan, P. Y., Shaik, A. A., Gunaratne, J., Dunne, M. J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3413 · Cited by 89
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
Gupta, I., Singh, K., Varshney, N. K., & Khan, S. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00011 · Cited by 93
Bettayeb, K., Baunbæk, D., Delehouzé, C., Loaëc, N., Hole, A. J., Baumli, S., Endicott, J., Douc‐Rasy, S., Bénard, J., Oumata, N., et al. (2010) · Genes & Cancer · doi:10.1177/1947601910369817 · Cited by 98
Li, L., Liu, T., Li, Y., Wu, C., Luo, K., Yin, Y., Chen, Y., Nowsheen, S., Wu, J., Lou, Z., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0134-2 · Cited by 92
Wu, X., Luo, Q., & Liu, Z. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02760-y · Cited by 99
Regulation of Neutrophil Survival/Apoptosis by Mcl-1
Milot, É., & Filep, J. G. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/131539 · Cited by 98
Fischer, A., Harrison, K. S., Ramírez, Y. A., Auer, D., Chowdhury, S. R., Prusty, B. K., Sauer, F., Dimond, Z. E., Kisker, C., Hefty, P. S., et al. (2017) · eLife · doi:10.7554/elife.21465 · Cited by 83
Elgendy, M., Ciro, M., Abdel-Aziz, A. K., Belmonte, G., Zuffo, R. D., Mercurio, C., Miracco, C., Lanfrancone, L., Foiani, M., & Minucci, S. (2014) · Nature Communications · doi:10.1038/ncomms6637 · Cited by 83
Novel strategies to target the ubiquitin proteasome system in multiple myeloma
Lub, S., Maes, K., Menu, E., Bruyne, E. D., Vanderkerken, K., & Valckenborgh, E. V. (2015) · Oncotarget · doi:10.18632/oncotarget.6658 · Cited by 99
PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation
Shen, S.-M., Zhang, C., Ge, M.-K., Dong, S.-S., Li, X., He, P., Zhang, N., Ji, Y., Yang, S., Yu, Y., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0409-z · Cited by 87
Li, C., Deng, C., Pan, G., Wang, X., Zhang, K., Dong, Z., Zhao, G., Tan, M., Hu, X., Shi, S., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01743-3 · Cited by 91
Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors
LaPlante, G., & Zhang, W. (2021) · Cancers · doi:10.3390/cancers13123079 · Cited by 92
Targeting MCL-1 protein to treat cancer: opportunities and challenges
Tantawy, S. I., Timofeeva, N., Sarkar, A., & Gandhi, V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1226289 · Cited by 90
Exploiting the pro-apoptotic function of NOXA as a therapeutic modality in cancer
Guikema, J. E. J., Amiot, M., & Eldering, E. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1349754 · Cited by 87
Karpel‐Massler, G., Horst, B. A. J., Shu, C., Chau, L., Tsujiuchi, T., Bruce, J. N., Canoll, P., Greene, L. A., Angelastro, J. M., & Siegelin, M. D. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2827 · Cited by 86
The Gag protein PEG10 binds to RNA and regulates trophoblast stem cell lineage specification
Abed, M., Verschueren, E., Budayeva, H., Liu, P., Kirkpatrick, D. S., Reja, R., Kummerfeld, S. K., Webster, J. D., Gierke, S., Reichelt, M., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214110 · Cited by 79
Self-citationRole of Deubiquitinating Enzymes in DNA Repair
Kee, Y., & Huang, T. T. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00847-15 · Cited by 80
Regulation of XIAP Turnover Reveals a Role for USP11 in Promotion of Tumorigenesis
Zhou, Z., Luo, A., Shrivastava, I. H., He, M., Huang, Y., Bahar, İ., Liu, Z., & Wan, Y. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.12.014 · Cited by 81
Wu, J., Wenzheng, G., Donghua, W., Guangyu, H., Aiping, Z., & Wu, W. (2018) · Cancer Medicine · doi:10.1002/cam4.1675 · Cited by 81
Role and Regulation of Pro-survival BCL-2 Proteins in Multiple Myeloma
Slomp, A., & Peperzak, V. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00533 · Cited by 80
Loss of Usp9x Disrupts Cortical Architecture, Hippocampal Development and TGFβ-Mediated Axonogenesis
Stegeman, S., Jolly, L. A., Premarathne, S., Gécz, J., Richards, L. J., Mackay‐Sim, A., & Wood, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068287 · Cited by 90
Naturally Occurring Isothiocyanates Exert Anticancer Effects by Inhibiting Deubiquitinating Enzymes
Lawson, A. P., Long, M. J. C., Coffey, R., Yu, Q., Weerapana, E., Oualid, F. E., & Hedstrom, L. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-1544 · Cited by 86
Wu, H., Medeiros, L. J., & Young, K. H. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.08.004 · Cited by 85
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
Peddaboina, C. S., Jupiter, D. C., Fletcher, S., Yap, J. L., Rai, A., Tobin, R. P., Jiang, W., Rascoe, P. A., Rogers, M. K. N., Smythe, W. R., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-541 · Cited by 82
Ubiquitin C-Terminal Hydrolase-L1 Potentiates Cancer Chemosensitivity by Stabilizing NOXA
Brinkmann, K., Zigrino, P., Witt, A., Schell, M. J., Ackermann, L., Broxtermann, P. N., Schüll, S., Andree, M., Coutelle, O., Yazdanpanah, B., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.02.014 · Cited by 79
Karpel‐Massler, G., Ishida, C. T., Bianchetti, E., Shu, C., Pérez‐Lorenzo, R., Horst, B. A. J., Banu, M. A., Roth, K. A., Bruce, J. N., Canoll, P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3424 · Cited by 79
Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress
Dong, L., Jiang, C. C., Thorne, R. F., Croft, A. J., Yang, F., Liu, H., de Bock, C. E., Hersey, P., & Zhang, X. D. (2011) · Oncogene · doi:10.1038/onc.2011.87 · Cited by 80
Reiner, T., Parrondo, R. D., Pozas, A. D. L., Palenzuela, D. L., & Perez‐Stable, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056234 · Cited by 88
The Amazing Ubiquitin-Proteasome System: Structural Components and Implication in Aging
Tsakiri, E. N., & Trougakos, I. P. (2014) · International review of cytology · doi:10.1016/bs.ircmb.2014.09.002 · Cited by 83
Yi, Y. W., Hong, W., Kang, H. J., Kim, H. J., Zhao, W., Wang, A., Seong, Y., & Bae, I. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12046 · Cited by 84
Chen, W., Zhou, Y., Zhi, X., Ma, T., Liu, H., Chen, B. W., Zheng, X., Xie, S., Zhao, B., Feng, X., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.11.035 · Cited by 77
Boiani, M., Daniel, C. K., Liu, X., Hogarty, M. D., & Marnett, L. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.414177 · Cited by 83
EGF-mediated induction of Mcl-1 at the switch to lactation is essential for alveolar cell survival
Fu, N. Y., Rios, A. C., Pal, B., Soetanto, R., Lun, A. T. L., Liu, K., Beck, T. J., Best, S. A., Vaillant, F., Bouillet, P., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3117 · Cited by 91
Gupta, S. C., Phromnoi, K., & Aggarwal, B. B. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.12.018 · Cited by 76
Arai, S., Jonas, O., Whitman, M. A., Corey, E., Balk, S. P., & Chen, S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0549 · Cited by 74
Seizures Are Regulated by Ubiquitin-specific Peptidase 9 X-linked (USP9X), a De-Ubiquitinase
Paemka, L., Mahajan, V. B., Ehaideb, S. N., Skeie, J. M., Tan, M. C., Wu, S., Cox, A., Sowers, L. P., Gécz, J., Jolly, L. A., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005022 · Cited by 77
Liu, H., Chen, W., Liang, C., Chen, B. W., Zhi, X., Zhang, S., Zheng, X., Bai, X., & Liang, T. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.001 · Cited by 78
Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy
Ma, B., Yuan, Z., Zhang, L., Lv, P., Yang, T., Gao, J., Pan, N., Wu, Q., Lou, J., Han, C., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.05.008 · Cited by 74
Pinto-Fernandez, A., & Kessler, B. M. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00133 · Cited by 73
Functional analysis of deubiquitylating enzymes in tumorigenesis and development
Cheng, J., Guo, J., North, B. J., Wang, B., Cui, C., Li, H., Tao, K., Zhang, L., & Wei, W. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188312 · Cited by 86
Targeting the ubiquitin proteasome system in haematological malignancies
Crawford, L., & Irvine, A. E. (2013) · Blood Reviews · doi:10.1016/j.blre.2013.10.002 · Cited by 83
Regulation of the DNA damage response by ubiquitin conjugation
Brinkmann, K., Schell, M. J., Hoppe, T., & Kashkar, H. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00098 · Cited by 84
Wu, X., Luo, Q., Zhao, P., Chang, W., Wang, Y., Shu, T., Ding, F., Li, B., & Liu, Z. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0339-0 · Cited by 80
Cui, J. R., Sun, W., Hao, X., Wei, M., Su, X., Zhang, Y., Su, L., & Liu, X. (2015) · Cancer Cell International · doi:10.1186/s12935-014-0149-x · Cited by 76
Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis
Wang, B., Xie, M., Li, R., Owonikoko, T. K., Ramalingam, S. S., Khuri, F. R., Curran, W. J., Wang, Y., & Deng, X. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.42 · Cited by 74
Regulating cell death at, on, and in membranes
Chi, X., Kale, J., Leber, B. F., & Andrews, D. W. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.06.002 · Cited by 85
Schwartzman, O., Savino, A. M., Gombert, M., Palmi, C., Cario, G., Schrappe, M., Eckert, C., von Stackelberg, A., Huang, J.-Y., Hameiri-Grossman, M., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702489114 · Cited by 69
TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1
Lionnard, L., Duc, P., Brennan, M. S., Kueh, A. J., Pál, M., Guardia, F., Mojsa, B., Damiano, M. A., Mora, S., Lassot, I., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0169-5 · Cited by 74
Fiskus, W., Cai, T., DiNardo, C. D., Kornblau, S. M., Borthakur, G., Kadia, T. M., Pemmaraju, N., Bose, P., Masarova, L., Rajapakshe, K., et al. (2019) · Blood Cancer Journal · doi:10.1038/s41408-018-0165-5 · Cited by 62
Zhan, Z., Li, Q., Wu, P., Ye, Y., Tseng, H.-Y., Zhang, L., & Zhang, X. D. (2012) · Autophagy · doi:10.4161/auto.8.1.18319 · Cited by 69
BCL2 Family, Mitochondrial Apoptosis, and Beyond
Dai, H., Meng, W., & Kaufmann, S. H. (2016) · Cancer translational medicine · doi:10.4103/2395-3977.177558 · Cited by 82
Wei, R., Liu, X., Yu, W., Yang, T., Cai, W., Liu, J., Huang, X. S., Xu, G., Zhao, S., Yang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3671 · Cited by 79
Self-citationProgramming cancer cells for high expression levels of Mcl1
Ertel, F., Nguyen, M., Roulston, A., & Shore, G. C. (2013) · EMBO Reports · doi:10.1038/embor.2013.20 · Cited by 76
Choi, Y. B., & Harhaj, E. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004458 · Cited by 75
Han, K.-J., Foster, D. G., Zhang, N., Kavdia, K., Dzieciątkowska, M., Sclafani, R. A., Hansen, K. C., Peng, J., & Liu, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.372318 · Cited by 71
Craxton, A., Butterworth, M., Harper, N., Fairall, L., Schwabe, J. W. R., Ciechanover, A. J., & Cohen, G. M. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.16 · Cited by 76
Karpel‐Massler, G., Bâ, M., Shu, C., Halatsch, M., Westhoff, M., Bruce, J. N., Canoll, P., & Siegelin, M. D. (2015) · Oncotarget · doi:10.18632/oncotarget.5505 · Cited by 71
Coughlin, K. A., Anchoori, R. K., Iizuka, Y., Meints, J. P., MacNeill, L., Vogel, R. I., Orlowski, R. Z., Lee, M. K., Roden, R. B. S., & Bazzaro, M. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2658 · Cited by 74
Thomas, D., Powell, J. A., Vergez, F., Segal, D., Nguyen, N.-Y. N., Baker, A., Teh, T., Barry, E. F., Sarry, J., Lee, E. M., et al. (2013) · Blood · doi:10.1182/blood-2012-08-447441 · Cited by 76
Self-citationYan, J., Zhong, N., Liu, G., Chen, K., Liu, X., Su, L., & Singhal, S. K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.281 · Cited by 72
Post-translational modification of mitochondria as a novel mode of regulation
Hofer, A., & Wenz, T. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.03.006 · Cited by 78
Fassl, A., Tagscherer, K. E., Richter, J., Díaz, M. B., Llaguno, S. R. A., Campos, B., Kopitz, J., Herold‐Mende, C. C., Herzig, S., Schmidt, M. H. H., et al. (2012) · Oncogene · doi:10.1038/onc.2011.615 · Cited by 63
Engel, K. C., Rudelius, M., Slawska, J., Jacobs, L., Abhari, B. A., Altmann, B., Kurutz, J., Rathakrishnan, A., Fernández‐Sáiz, V., Brunner, A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201506047 · Cited by 67
FBW7 -Dependent Mcl-1 Degradation Mediates the Anticancer Effect of Hsp90 Inhibitors
Tong, J., Tan, S., Nikolovska‐Coleska, Z., Yu, J., Zou, F., & Zhang, L. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0032 · Cited by 68
Jing, C., Duan, Y., Zhou, M., Yue, K., Zhuo, S., Li, X., Liu, D., Ye, B., Lai, Q., Li, L., et al. (2021) · Theranostics · doi:10.7150/thno.48375 · Cited by 74
Mitochondria as Therapeutic Targets for the Treatment of Malignant Disease
Fulda, S., & Kroemer, G. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4078 · Cited by 69
The E3 ligase Itch in immune regulation and beyond
Aki, D., Zhang, W., & Liu, Y. (2015) · Immunological Reviews · doi:10.1111/imr.12301 · Cited by 71
Peng, J., Hu, Q., Liu, W., He, X., Cui, L., Chen, X., Yang, M., Liu, H., Wei, W., Liu, S., et al. (2013) · Diagnostic Pathology · doi:10.1186/1746-1596-8-177 · Cited by 69
Regulation of proximal T cell receptor signaling and tolerance induction by deubiquitinase Usp9X
Naik, E., Webster, J. D., DeVoss, J., Liu, J., Suriben, R., & Dixit, V. M. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140860 · Cited by 70
Self-citationPotu, H., Peterson, L. F., Kandarpa, M., Pal, A., Sun, H., Durham, A. B., Harms, P. W., Hollenhorst, P. C., Eskiocak, U., Talpaz, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14449 · Cited by 69
Deubiquitinase USP9x Confers Radioresistance through Stabilization of Mcl-1
Trivigno, D., Eßmann, F., Huber, S. M., & Rudner, J. (2012) · Neoplasia · doi:10.1593/neo.12598 · Cited by 69
Interplay between protein acetylation and ubiquitination controls MCL1 protein stability
Shimizu, K., Gi, M., Suzuki, S., North, B. J., Watahiki, A., Fukumoto, S., Asara, J. M., Tokunaga, F., Wei, W., & Inuzuka, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109988 · Cited by 62
“Although detailed molecular mechanisms need to be analyzed further, our findings provide a mechanistic explanation for the signal-dependent interaction between MCL1 and USP9X.”
InfluentialMaleńczyk, K., Girach, F., Szodorai, E., Storm, P., Segerstolpe, Å., Tortoriello, G., Schnell, R., Mulder, J., Romanov, R. A., Borók, E., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201695347 · Cited by 63
Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer
Jaiswal, A., Murakami, K., Elia, A., Shibahara, Y., Done, S. J., Wood, S. A., Donato, N. J., Ohashi, P. S., & Reedijk, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101592118 · Cited by 67
Metadata
- Authors
- Schwickart, M., Huang, X., Lill, J. R., Liu, J., Ferrando, R., French, D. M., Maecker, H., O’Rourke, K., Bazan, F., Eastham-Anderson, J., Yue, P., Dornan, D., Huang, D. C. S., & Dixit, V. M.
- Affiliations
- Genentech (US)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Corresponding author
- Dixit, Vishva M.
- Venue
- Nature
- Published
- 2009-12-20
- Volume
- 463
- Issue
- 7277
- Pages
- 103-107
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1991249033
- Cited by
- 628
- References
- 31
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 20 · 2023: 21 · 2022: 20 · 2021: 38 · 2020: 41 · 2019: 44 · 2018: 45 · 2017: 45 · 2016: 51 · 2015: 49 · 2014: 50 · 2013: 46 · 2012: 44
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- USP9X, Mcl-1, deubiquitinase, protein stabilization, ubiquitination, multiple myeloma, Bcl-2 family proteins, apoptosis, ABT-737, BH3 mimetics, follicular lymphoma, diffuse large B-cell lymphoma, chemoresistance, therapeutic target, prognosis, proteasomal degradation, stem/progenitor cells, tumor cell survival
- MeSH terms
- Docetaxel, Animals, Biphenyl Compounds, Cell Line, Cell Survival, DNA Damage, Etoposide, Female, Half-Life, Humans, Lysine, Neoplasms, Nitrophenols, Phosphorylation, Piperazines, Prognosis, Protein Binding, Sulfonamides, Ultraviolet Rays, Gene Expression Regulation, Neoplastic, Mice, SCID, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Xenograft Model Antitumor Assays, Polyubiquitin, RNA Interference, Ubiquitin Thiolesterase, Taxoids, Cell Line, Tumor, Mice, Ubiquitination, Protein Stability, Gene Knockdown Techniques, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.